Ahmer A. Qureshi

Ahmer A. Qureshi is an associate in the firm’s Business Law department and a member of its Private Equity group. Ahmer’s practice focuses primarily on merger and acquisitions and private equity investments across a broad range of industries. Ahmer represents private equity sponsors and their portfolio companies, as well as strategic buyers and search fund clients in connection with investment transactions, leveraged buyouts, and general corporate matters. In addition, he represents domestic and non-US companies in mergers and acquisitions.

Prior to joining Goodwin in 2021, Ahmer was a corporate associate at Greenberg Traurig, LLP in Boston.

Ahmer’s recent experience includes representing:

• Avery Dennison (NYSE: AVY) in its acquisition of Lion Brothers
• Novo Holdings in its acquisition of KabaFusion
• TA Associates in its $2.5 billion acquisition of Veracode
• Singapore Telecommunications Limited in its sale of Amobee to Tremor International for $239 million
• Novo Holdings in its acquisition of Ritedose Corporation from AGIC Capital and Humanwell
• Marlin Equity Partners in the sale of True Office Learning to Learning Pool
• Family-owned consumer products company in $1.6 billion sale to a major private equity firm
• TA Associates in its strategic investment in Death Wish Coffee
• Bugsnag in connection with its sale to SmartBear, a Vista Equity and Francisco Partners portfolio company

Representative Search Fund Transactions:

• A private equity search fund in its equity investment and acquisition of a marketing agency
• A private equity search fund in its equity investment and acquisition of a water metering company
• A private equity search fund in its equity investment and acquisition of a home infusion and specialty pharmacy company

• Author, “Coronavirus & Contracts: How the Coronavirus May Trigger Force Majeure,” American Journal of Law and Medicine, May 27, 2020
• Author, “Going Up in Smoke: Altria's Bet on JUUL in Jeopardy,” American Journal of Law and Medicine, January 23, 2020